Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.

A novel electrocardiographic index for the diagnosis of diastolic dysfunction.

Namdar M, Biaggi P, Stähli B, Bütler B, Casado-Arroyo R, Ricciardi D, Rodríguez-Mañero M, Steffel J, Hürlimann D, Schmied C, de Asmundis C, Chierchia GB, Sarkozy A, Lüscher TF, Jenni R, Duru F, Paulus WJ, Brugada P.

PLoS One. 2013 Nov 5;8(11):e79152. doi: 10.1371/journal.pone.0079152. eCollection 2013.

2.

The effect of diabetic autonomic neuropathy on P-wave duration, dispersion and atrial fibrillation.

Bissinger A, Grycewicz T, Grabowicz W, Lubinski A.

Arch Med Sci. 2011 Oct;7(5):806-12. doi: 10.5114/aoms.2011.25555. Epub 2011 Nov 8.

3.

Increased p wave dispersion in elite athletes.

Puerta RC, Aliz EL, Lopez-Calleja MA, Ramirez RR, Pena GP.

Indian Pacing Electrophysiol J. 2011 May 1;11(3):73-80.

4.

Exponential distribution of long heart beat intervals during atrial fibrillation and their relevance for white noise behaviour in power spectrum.

Hennig T, Maass P, Hayano J, Heinrichs S.

J Biol Phys. 2006 Nov;32(5):383-92. doi: 10.1007/s10867-006-9022-z. Epub 2006 Dec 15.

5.

Long-term outcomes in individuals with prolonged PR interval or first-degree atrioventricular block.

Cheng S, Keyes MJ, Larson MG, McCabe EL, Newton-Cheh C, Levy D, Benjamin EJ, Vasan RS, Wang TJ.

JAMA. 2009 Jun 24;301(24):2571-7. doi: 10.1001/jama.2009.888.

6.

Nebivolol and quinapril reduce p-wave duration and dispersion in hypertensive patients.

Korkmaz H, Onalan O, Akbulut M, Ozbay Y.

Indian Pacing Electrophysiol J. 2009 May 15;9(3):158-66.

7.

Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study.

Schnabel RB, Sullivan LM, Levy D, Pencina MJ, Massaro JM, D'Agostino RB Sr, Newton-Cheh C, Yamamoto JF, Magnani JW, Tadros TM, Kannel WB, Wang TJ, Ellinor PT, Wolf PA, Vasan RS, Benjamin EJ.

Lancet. 2009 Feb 28;373(9665):739-45. doi: 10.1016/S0140-6736(09)60443-8.

8.

Prolonged signal-averaged P-wave duration as an intermediate phenotype for familial atrial fibrillation.

Darbar D, Hardy A, Haines JL, Roden DM.

J Am Coll Cardiol. 2008 Mar 18;51(11):1083-9. doi: 10.1016/j.jacc.2007.11.058.

9.

Atrial fibrillation and revascularization procedures: clinical and prognostic significance. Incidence, predictors, treatment, and long-term outcome.

Terranova P, Carletti F, Valli P, Dell'Orto S, Enrico Maria G, Terranova P.

Indian Pacing Electrophysiol J. 2007 Jan 1;7(1):50-60. No abstract available.

Supplemental Content

Support Center